Evidence map›Paper›PMID 30706099›Full record

ReviewPsychopharmacology2019

Exploring cocoa properties: is theobromine a cognitive modulator?

Ilaria Cova, V Leta, C Mariani, L Pantoni, S Pomati

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Psychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04389723 (A Randomized, Double-blind, Placebo-controlled, Crossover Study to Investigate the Safety and Efficacy of Qualia Mind on Cognition in a Healthy Population), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04389723 nacompletednot on this mapstarted 2020, after this paper: background citation

A Randomized, Double-blind, Placebo-controlled, Crossover Study to Investigate the Safety and Efficacy of Qualia Mind on Cognition in a Healthy Population

TypeinterventionalSponsorNeurohacker CollectiveRan2020 to 2020Enrolled60ConditionsHealthy, Cognitive FunctionArmsQualia Mind, Placebo
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Taste Masking of Steroids for Oral Formulations.Turkish journal of pharmaceutical sciences · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. In Pursuit of Healthy Aging: Effects of Nutrition on Brain Function.International journal of molecular sciences · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ilaria CovaCenter for Research and Treatment on Cognitive Dysfunctions, Neurology Unit, L. Sacco University Hospital, Via G.B. Grassi, 74, I-20157, Milan, Italy. ilaria.cova@unimi.it.ORCID http://orcid.org/0000-0001-7831-6791
V LetaCenter for Research and Treatment on Cognitive Dysfunctions, Neurology Unit, L. Sacco University Hospital, Via G.B. Grassi, 74, I-20157, Milan, Italy.
C MarianiDepartment of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
L PantoniDepartment of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
S PomatiCenter for Research and Treatment on Cognitive Dysfunctions, Neurology Unit, L. Sacco University Hospital, Via G.B. Grassi, 74, I-20157, Milan, Italy.
University of Milan · ITLuigi Sacco Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nutritional qualities of cocoa have been acknowledged by several authors; a particular focus has been placed on its high content of flavanols, known for their excellent antioxidant properties and subsequent protective effect on cardio- and cerebrovascular systems as well as for neuromodulatory and neuroprotective actions. Other active components of cocoa are methylxanthines (caffeine and theobromine). Whereas the effects of caffeine are extensively researched, the same is not the case for theobromine; this review summarizes evidence on the effect of theobromine on cognitive functions. Considering animal studies, it can be asserted that acute exposition to theobromine has a reduced and delayed nootropic effect with respect to caffeine, whereas both animal and human studies suggested a potential neuroprotective action of long-term assumption of theobromine through a reduction of Aβ amyloid pathology, which is commonly observed in Alzheimer's disease patients' brains. Hence, the conceivable action of theobromine alone and associated with caffeine or other cocoa constituents on cognitive modulation is yet underexplored and future studies are needed to shed light on this promising molecule.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsCacaoCaffeineCentral Nervous System StimulantsCognitionHumansNootropic AgentsPolyphenolsTheobromineAmyloid beta-PeptidesCaffeineCentral Nervous System StimulantsNootropic AgentsPolyphenolsTheobromineCocoaCognitionCognitive modulatorTheobromine

Identifiers

PMID30706099
OpenAlexW2911570927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.